DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Martin Shkreli
Martin Shkreli
Case Study
A Look at the Legality Behind Daraprim's Price Spike Law360, New York (September 30, 2015, 12:15 PM ET)
Notorious Turing CEO Martin Shkreli Arrested for Securities Fraud Like Share Tweet Share
Attorney General Herring Files Suit Against Martin
Outline of Selected SEC Enforcement Actions, Division of Enforcement (October 2016)
Media Physicians Public
The Next President Can Lower Drug Prices with the Stroke of a Pen
Imbeaumbsthesis.Pdf (2.574Mb)
Complaint: Martin Shkreli, Evan Greebel, MSMB Capital
Mlex Op-Ed: Wilson Says Pandemic Underscores Need to Establish
Seven Commandments of Esports Communications
Shkreli, Martin
Bloomberg Brief: Hedge Funds ACTIVIST
Hedge Papers, Trump's Wealthcare Plan
Turing Pharmaceuticals
Martin Shkreli Verdict Date
Overpriced and Under Regulated: a Crackdown on Pharmaceutical Monopolization and Malfeasance
The Drug Price Dilemma
Top View
Hillary Clinton Calls for U.S. Probe of 5,000% Drug Price Hike
The Cost of High Prices: Embedding an Ethic of Expense Into the Standard of Care, 58 B.C.L
Attorney General James Sues 'Pharma Bro' Martin Shkreli And
Lowering Drug Prices
Attorney General Becerra Files Lawsuit Against 'Pharma Bro' Martin
US Fraud Trial Underway for Pharma Bad Boy Shkreli 29 June 2017
Six More States Join FTC and NY Attorney General's Case Against
2 0 Cv 00706 in the United States District Court ·
Big Pharma Wields Its Power with the Help of Government Regulation
Epipen: out of Reach
Drug Price Gouging: Will There Ever Be an End?
Sudden Price Spikes in Off-Patent Prescription Drugs: the Monopoly Business Model That Harms Patients, Taxpayers, and the U.S
Daraprim Price Increase and Utilization
Martin Shkreli
What the Daraprim Price Hike Actually Does to Health Care
Clinton Takes on Big Pharma, Lays out Drug Plan (Update) 23 September 2015
United States of America
Shkreli's Sentence Shows Risks of Open Defiance by Stewart Bishop